EMEA-000609-PIP01-09-M01

  • Email
  • Help

Overview

Product details for -
Invented name-
Active substance

Recombinant human glutamic acid decarboxylase (rhGAD65)

Decision numberP/0400/2017
PIP numberEMEA-000609-PIP01-09-M01
Pharmaceutical form(s)Suspension for injection
Condition(s)/indication(s)

Treatment of type I diabetes mellitus

Route(s) of administrationSubcutaneous use
PIP applicant

Diamyd Therapeutics AB
Tel. +46 86610026
E-mail: anton.lindqvist@diamyd.com
clinicaltrials@diamyd.com

Decision typeRPM: decision refers to a refusal on the application for modifiction of an agreed PIP

Decision